• Citer

Predictive factors of non-completion of cytoreductive surgery in colorectal peritoneal metastasis

par Boldrin, Veronica;Khaled, Charif ;El Asmar, Antoine ;Kamden, Leonel;Sclafani, Francesco ;Gomez Garcia, Maria ;Moreau, Michel ;Vouche, Michael ;Liberale, Gabriel
Référence European journal of surgical oncology, page (107251)
Publication Publié, 2023-11-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

Cytoreductive surgery (CRS) ± hyperthermic intraperitoneal chemotherapy (HIPEC) is the only potentially curative treatment that can improve the survival prognosis for patients with peritoneal metastasis (PM) of colorectal origin. The main independent prognostic factors are extent of disease, as measured by the Peritoneal Cancer Index (PCI), and completion of CRS (CC-0 or R1). Despite thorough preoperative work-up for selection of surgical candidates, 20%-25 % of CRS procedures are stopped after exploration during laparotomy. These patients undergo "open-and-close" procedures associated with a risk of complications and without any benefit. The aim of this study was to identify preoperative predictors of non-resectability and/or non-completion of CRS in patients with colorectal PMs who were candidates for surgery.